PubMedCrossRef 2. Roilides E, Butler KM, Husson RN, Mueller BU, Lewis LL, Pizzo PA: Pseudomonas infections in children with human immunodeficiency virus infection. Pediatr Infect Dis J 1992, 11:547–553.PubMedCrossRef 3. Vartivarian SE, Papadakis KA, Anaissie EJ: Stenotrophomonas ( Xanthomonas ) maltophilia urinary tract infection. A disease that is usually severe and complicated. Arch Intern Med 1996, 156:433–435.PubMedCrossRef 4. Chang HC, Chen CR, Lin JW, Shen GH, Chang KM, Tseng YH, Weng SF: Isolation and characterization of novel giant Stenotrophomonas maltophilia phage phiSMA5. Appl Environ Microbiol C188-9 2005, 71:1387–1393.PubMedCentralPubMedCrossRef 5. Caylan R, Kaklikkaya N, Aydin K, Aydin F, Yilmaz G, Ozgumus
B, Koksal I: An epidemiological analysis of Stenotrophomonas maltophilia strains in a university hospital. Jpn J Infect Dis 2004, 57:37–40.PubMed 6. Milne KE, Gould IM: Combination antimicrobial susceptibility testing of multidrug-resistant Stenotrophomonas maltophilia from cystic fibrosis patients. Antimicrob Agents Chemother 2012, 56:4071–4077.PubMedCentralPubMedCrossRef 7. Harper DR, Enright MC: Bacteriophages for the treatment of Pseudomonas aeruginosa infections. J Appl Microbiol 2011, 111:1–7.PubMedCrossRef 8. Chen CR, Lin CH, Lin JW, Chang CI, Tseng YH, Weng SF: Characterization of PARP inhibitor a novel T4-type Stenotrophomonas
maltophilia virulent phage Smp14. Arch Microbiol 2007, 188:191–197.PubMedCrossRef 9. Huang Y, Fan H, Pei G, Fan H, Zhang Z, An X, Mi Z, Shi T, Tong Y: Complete genome sequence of IME15, the first T7-like bacteriophage lytic to pan-antibiotic-resistant Stenotrophomonas maltophilia . J Virol 2012, 86:13839–13840.PubMedCentralPubMedCrossRef 10. Fan H, Huang Y, Mi Z, Yin X, Wang L, Fan H, Zhang Z, An X, Chen J, Tong Y: Complete Genome Sequence of IME13, a Stenotrophomonas maltophilia bacteriophage with large burst size and unique plaque polymorphism. J Virol 2012, 86:11392–11393.PubMedCentralPubMedCrossRef 11. Liu J, Chen P, Zheng C, Huang YP: Characterization of maltocin P28, a novel phage tail-like bacteriocin
from Stenotrophomonas maltophilia . Appl Environ Microbiol 2013, 79:5593–5600.PubMedCrossRef 12. Hagemann M, Hasse D, Berg G: Detection of a phage genome carrying a zonula occludens like toxin gene (zot) in clinical isolates of Stenotrophomonas not maltophilia . Arch Microbiol 2006, 185:449–458.PubMedCrossRef 13. Liu J, Liu Q, Shen P, Huang YP: Isolation and characterization of a novel filamentous phage from Stenotrophomonas maltophilia . Arch Virol 2012, 157:1643–1650.PubMedCrossRef 14. Petrova M, Shcherbatova N, Kurakov A, Mindlin S: Genomic characterization and integrative properties of phiSMA6 and phiSMA7, two novel filamentous bacteriophages of Stenotrophomonas maltophilia. Arch Virol 2013. [Epub ahead of print] 15. Lee CN, Lin JW, Chow TY, Tseng YH, Weng SF: A novel lysozyme from Xanthomonas oryzae phage ϕXo411 active against Xanthomonas and Stenotrophomonas . Protein Expr Purif 2006, 50:229–237.